Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Nuchev Pty Ltd ( (AU:NUC) ) has shared an announcement.
Nuchev Pty Ltd reported a significant revenue increase of 110% for the fiscal year ending June 2025, driven by strong sales in nutritional and dietary supplements. The company improved its net contribution margin and reduced its operating loss, signaling progress towards profitability. Strategic moves, including the acquisition of bWellness and expansion into new markets, have strengthened its market position. The company ended the year with a positive cash position and no external debt, indicating robust financial health.
The most recent analyst rating on (AU:NUC) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.
More about Nuchev Pty Ltd
Nuchev Pty Ltd operates in the nutritional and dietary supplements industry, focusing on products such as Oli6® Nutritional and various Practitioner channel offerings. The company has expanded its market presence through acquisitions like bWellness and aims to grow its footprint in the Vietnam market.
Average Trading Volume: 35,627
Technical Sentiment Signal: Sell
Current Market Cap: A$24.89M
For detailed information about NUC stock, go to TipRanks’ Stock Analysis page.